Left and right ventricular structural changes in obese hypertensives

Meilikemu Masaidi1, Cesare Cuspidi, Francesca Negri

  • 1Istituto di Medicina Cardiovascolare, Ospedale Maggiore Policlinico, Italy.

Blood Pressure
|April 9, 2009
PubMed

Insights

Obesity significantly increases the risk of biventricular hypertrophy in patients with essential hypertension. This finding highlights the critical impact of body mass index on cardiac structure in hypertensive individuals.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Obesity Medicine

Background:

  • Obesity is a known risk factor for left ventricular hypertrophy (LVH).
  • The association between obesity and right ventricular hypertrophy (RVH) in human hypertension remains unclear.
  • This study investigates obesity's link to RVH and biventricular hypertrophy in essential hypertension.

Purpose of the Study:

  • To determine the relationship between obesity and right ventricular hypertrophy (RVH).
  • To assess the association of obesity with biventricular hypertrophy in essential hypertension.
  • To identify obesity as a predictor of cardiac structural changes in hypertensive patients.

Main Methods:

  • A cohort of essential hypertensive patients was categorized by body mass index (BMI) into three groups: normal (<25 kg/m²), overweight (25-29.9 kg/m²), and obese (≥30 kg/m²).
  • Right ventricular hypertrophy (RVH) was defined by anterior RV wall thickness.
  • Left ventricular hypertrophy (LVH) was assessed using left ventricular mass index (LVMI).

Main Results:

  • Obesity prevalence was 16.7% in the cohort.
  • Biventricular hypertrophy rates increased significantly with BMI, from 7.3% in normal BMI to 32.7% in obese patients.
  • Multivariate analysis identified BMI as the strongest correlate of biventricular hypertrophy (OR=3.58, p=0.0002).

Conclusions:

  • Obesity is strongly associated with biventricular hypertrophy in essential hypertension.
  • These findings confirm and extend previous research on obesity's detrimental effects on cardiac structure.
  • Body mass index is a key factor in the development of cardiac remodeling in hypertensive individuals.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...